Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
WORLD
Dec 17, 2020
WHO plan risks leaving poor nations with no COVID-19 vaccines until 2024
Documents show the program's promoters say it is struggling from a lack of funds, supply risks and complex contractual arrangements which could make it impossible to achieve its goals.
Japan Times
ASIA PACIFIC / Science & Health
Dec 16, 2020
With goal of herd immunity, Indonesia will give younger people vaccines first
The country is targeting the people who are most mobile due to their jobs, as well as regions with the highest number of coronavirus cases.
Japan Times
WORLD
Dec 15, 2020
A weapon to ‘win the war’: U.S. hospitals get initial coronavirus shots
The arrival of the Pfizer-BioNTech vaccine offers a glimmer of hope amid a pandemic that has already seen almost 300,000 Americans die.
Japan Times
ASIA PACIFIC
Dec 15, 2020
In Asia first, Singapore approves Pfizer's COVID-19 vaccine
Singapore has become the first Asian country to approve the Pfizer-BioNTech coronavirus vaccine and said it expects to start receiving shots by the end of the year.
Japan Times
BUSINESS
Dec 11, 2020
Why Japan is largely a spectator in the coronavirus vaccine race
A total of 52 vaccine candidates were in clinical evaluation worldwide as of Tuesday, of which only one was Japanese.
Japan Times
WORLD
Dec 10, 2020
U.S. nears final COVID-19 vaccine review as daily deaths top 3,250
Steady movement toward a vaccine rollout on the eve of a critical review by leading U.S. medical experts comes as COVID-19 caseloads surged alarmingly higher, straining health care systems.
Japan Times
WORLD / Science & Health
Dec 10, 2020
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
Japan Times
WORLD / Science & Health
Dec 9, 2020
China’s state-backed coronavirus vaccine has 86% efficacy, says UAE
China’s state-backed coronavirus vaccine protected 86% of people from getting COVID-19 in trials conducted in the United Arab Emirates, reported media outlets including Reuters, citing the UAE’s health ministry.
Japan Times
WORLD / Science & Health
Dec 9, 2020
Testing times: More work needed on AstraZeneca/Oxford vaccine trials
A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.
Japan Times
WORLD / Science & Health
Nov 29, 2020
COVID-19 drugs from Lilly and Regeneron raise access and timing concerns
Powerful drugs recently authorized by the U.S. that may prevent those at the earliest stages of COVID-19 from suffering severe disease present thorny new challenges, including who will get them and where they’ll be administered.
Japan Times
WORLD / Science & Health
Nov 26, 2020
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
Japan Times
WORLD / Science & Health
Nov 21, 2020
Two companies say their vaccines are 95% effective. What does that mean?
You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that's not how the math works.
Japan Times
WORLD / Science & Health
Nov 20, 2020
WHO advises doctors not to use Gilead’s remdesivir for COVID-19
The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Can first vaccines bring herd immunity? Experts have doubts.
Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
China takes risk in rushing to use unproven coronavirus vaccines
China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
Sinovac's COVID-19 vaccine induces quick immune response, study finds
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.

Longform

Sociologist Gracia Liu-Farrer argues that even though immigration doesn't figure into Japan's autobiography, it is more of a self-perception than a reality.
In search of the ‘Japanese dream’